ABSTRACT
For patients with atherosclerotic coronary artery disease (CAD), each 1-MET increase in exercise capacity is associated with a 15% reduction in cardiovascular mortality, which compares favorably with the survival benefit conferred by commonly prescribed cardioprotective medications after acute myocardial infarction (AMI).
